Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by MF Thomas
S72 Paediatric Pneumococcal Empyema Serotypes Have Not Changed Following Introduction of the 13 Valent Pneumococcal Vaccine
Thorax
Pulmonary
Respiratory Medicine
Insulin-Like Growth Factor-I Protects Myoblasts From Apoptosis but Requires Other Factors to Stimulate Proliferation
Journal of Endocrinology
Endocrinology
Metabolism
Diabetes
Related publications
Increased Paediatric Hospitalizations for Empyema in Australia After Introduction of the 7-Valent Pneumococcal Conjugate Vaccine
Bulletin of the World Health Organization
Environmental
Public Health
Occupational Health
Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in an Isolated Pneumococcal Vaccine-Naïve Indigenous Population
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Clinical Efficacy of Pneumococcal Conjugate 13-Valent Vaccine in Young Children
Pediatric pharmacology
Pediatric Invasive Pneumococcal Disease Caused by Vaccine Serotypes Following the Introduction of Conjugate Vaccination in Denmark
PLoS ONE
Multidisciplinary
Immunogenicity and Tolerance of a 7-Valent Pneumococcal Conjugate Vaccine in Nonresponders to the 23-Valent Pneumococcal Vaccine
Infection and Immunity
Parasitology
Infectious Diseases
Immunology
Microbiology
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
MMWR. Morbidity and mortality weekly report
Health Information Management
Mutagenesis
Epidemiology
Health
Medicine
Toxicology
Aetiology of Paediatric Pneumonia After the Introduction of Pneumococcal Conjugate Vaccine
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Spatial Variability in the Persistence of Pneumococcal Conjugate Vaccine-Targeted Pneumococcal Serotypes Among Adults
Epidemiology
Epidemiology
PIN54 Cost-Effectiveness of 2+1 Dosing of 13-Valent Pneumococcal Conjugate Vaccine Compared With 2+1 Dosing of 10-Valent Conjugate Vaccine in Preventing Pneumococcal Disease in Canada
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental